CRNO TO1 B - Cereno Scientific AB News Story
SEK0.41 0.0 0.0%
Last Trade - 04/03/21
| Market Cap | £11.5m |
| Enterprise Value | £6.71m |
| Revenue | £n/a |
| Position in Universe | 1530th / 1850 |
BRIEF-Cereno Scientific Initiates Collaboration With Cro Partner Oct To Conduct A Phase Ii Study
Tue 26th June, 2018 7:48am
Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC INITIATES COLLABORATION WITH CRO PARTNER
OCT
TO CONDUCT A PHASE II STUDY
* CONDUCT A PHASE II STUDY TO INVESTIGATE ANTITHROMBOTIC
EFFECTS
OF CERENOS CANDIDATE DRUG CS1.
Source text for Eikon: ID:nWkr5br2V0
Further company coverage: CRNOSb.TE
Recent news on Cereno Scientific AB
See all news
